---
title: "Fuxin Technology: The preliminary inquiry transfer price is set at RMB 30.53 per share"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/247281716.md"
description: "According to the Zhitong Finance APP, Fuxin Technology disclosed the pricing situation for the transfer of shares through inquiries to shareholders. After inquiring with institutional investors, the preliminary transfer price determined for this inquiry transfer is RMB 30.53 per share. The shares intended for transfer in this inquiry have been fully subscribed, with the preliminary determination of the transferees being 13 institutional investors, and the total number of shares to be transferred is 2.6472 million shares"
datetime: "2025-07-04T09:42:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/247281716.md)
  - [en](https://longbridge.com/en/news/247281716.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/247281716.md)
generator: "portal-rs"
---

# Fuxin Technology: The preliminary inquiry transfer price is set at RMB 30.53 per share

According to the Zhitong Finance APP, Fuxin Technology (688662.SH) disclosed the pricing situation for the inquiry transfer by shareholders. After inquiring institutional investors, the preliminary transfer price determined for this inquiry transfer is RMB 30.53 per share. The shares intended for transfer in this inquiry have been fully subscribed, with the preliminary determination of the transferees being 13 institutional investors, with a total number of shares to be transferred amounting to 2.6472 million shares

### Related Stocks

- [688662.CN](https://longbridge.com/en/quote/688662.CN.md)

## Related News & Research

- [Brandenburg Kapital joins AssistMe’s EUR 6.5 million financing round](https://longbridge.com/en/news/297893934.md)
- [11:07 ETEMQX Enterprise 6.3 Long-Term Support Release Strengthens Security for Production MQTT Deployments](https://longbridge.com/en/news/297933790.md)
- [TP: Monthly Information Regarding Shares and Voting Rights](https://longbridge.com/en/news/297678327.md)
- [Egetis says new Emcitate clinical data from Triac Trial II, ReTRIACt to be presented at September congresses](https://longbridge.com/en/news/297996002.md)
- [Platauro Metals Corp. - Star Project, Utah | MEXGF Stock News](https://longbridge.com/en/news/297781602.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**